Waltham biotech Morphic signs $725M partnership with Janssen

Preclinical biotech Morphic Therapeutic Inc. has signed its second major collaboration with a pharmaceutical giant, announcing a collaboration with Janssen Thursday worth more than $725 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.